Repligen Corporation to Present at KeyBanc Life Science and MedTech Investor Forum

Rhea-AI Summary

Repligen Corporation (NASDAQ:RGEN) will present virtually at the KeyBanc Life Science and MedTech Investor Forum on March 23-24, 2021. CEO Tony Hunt will participate in a fireside chat on March 24 at 9:15 a.m. EDT. The discussion will be available via live webcast on the company's Investor Relations website, with a replay accessible for a limited time post-event. Repligen specializes in innovative bioprocessing technologies, serving biopharmaceutical developers and contract manufacturers globally, with headquarters in Waltham, Massachusetts.

WALTHAM, Mass., March 17, 2021 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will present virtually at the KeyBanc Life Science and MedTech Investor Forum being held March 23-24.  Tony Hunt, President & Chief Executive Officer, will participate in a fireside chat on Wednesday, March 24, at 9:15 a.m. EDT.

A live webcast of the discussion will be accessible through the Investor Relations section of the Company’s website, and will be available for replay for a limited period of time following the conference event.

About Repligen Corporation

Repligen Corporation is a global life sciences company that develops and commercializes highly innovative bioprocessing technologies and systems that increase efficiencies in the process of manufacturing biological drugs. Our primary customers are biopharmaceutical drug developers and contract development and manufacturing organizations (CDMOs) worldwide. Our corporate headquarters are located in Waltham, Massachusetts, with additional administrative and manufacturing operations worldwide. The majority of our manufacturing sites are located within the U.S. (California, Massachusetts, New Jersey and New York), and outside of the U.S. we have sites in Estonia, Germany, Ireland, the Netherlands and Sweden.

Repligen Contact:
Sondra S. Newman
Global Head of Investor Relations
(781) 419-1881
investors@repligen.com

FAQ

When will Repligen Corporation present at the KeyBanc Investor Forum?

Repligen Corporation will present at the KeyBanc Life Science and MedTech Investor Forum on March 23-24, 2021.

What time is Tony Hunt's fireside chat at the Investor Forum?

Tony Hunt's fireside chat is scheduled for March 24, 2021, at 9:15 a.m. EDT.

Where can I watch the webcast of Repligen's presentation?

The webcast of Repligen's presentation will be accessible through the Investor Relations section of their website.

What is Repligen Corporation's focus in the life sciences sector?

Repligen Corporation focuses on developing innovative bioprocessing technologies for manufacturing biological drugs.

What markets does Repligen serve?

Repligen serves biopharmaceutical drug developers and contract development and manufacturing organizations worldwide.